ALKERMES | Satış Brüt Kar



Gross Profit On Sales Değişiklik Tarih
AbbVie USD 10.71B 458M 2024-12
Acadia Pharmaceuticals USD 237.8M 72.86M 2024-12
ALKERMES USD 146.5M 168.54M 2024-12
Amgen USD 5.97B 781M 2024-12
Biogen USD 1.87B 44.1M 2024-12
BioMarin Pharmaceutical USD 611.17M 53.89M 2024-12
Bristol-Myers Squibb USD 9.13B 94M 2024-12
Eli Lilly USD 11.13B 1.86B 2024-12
Gilead Sciences USD 5.99B 17M 2024-12
Intra Cellular Therapies USD 178.82M 18.75M 2024-12
Ionis Pharmaceuticals USD 222.75M 90M 2024-12
J&J USD 15.41B 102M 2024-12
Malin Corporation EUR 3.8M 2.6M 2020-12
Merck USD 11.92B 852M 2024-12
Neurocrine Biosciences USD 618.4M 4.3M 2024-12
Otsuka Holdings JPY 422.09B 32.52B 2024-12
Pfizer USD 12.11B 718M 2024-12
Regeneron Pharmaceuticals USD 3.22B 1.88B 2024-12
Vertex Pharmaceuticals USD 2.49B 109.3M 2024-12



ALKERMES Satış Brüt Kar - Akım değerleri, tarihsel veriler, tahminler, istatistikler, grafikler ve ekonomik takvim - Mar 2025.